Area of research
Radiology, Nuclear Medicine and Imaging · Immunology
Research interest
Research interests include Monoclonal and Polyclonal Antibodies Research, Mast cells and histamine, Immunotherapy and Immune Responses, and HER2/EGFR in Cancer Research.
Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction
Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in <scp>AllergoOncology</scp> : An <scp>EAACI</scp> Position Paper
Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma
Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An <scp>EAACI</scp> position paper
Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4
B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma
Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes
Clinical and Translational Significance of Basophils in Patients with Cancer
Enriched circulating and tumor-resident TGF-β <sup>+</sup> regulatory B cells in patients with melanoma promote FOXP3 <sup>+</sup> Tregs
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action
B Cells in Patients With Melanoma: Implications for Treatment With Checkpoint Inhibitor Antibodies
Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments
Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome
IgE Antibodies against Cancer: Efficacy and Safety